Lyophilization USA Conference

Iselin, NJ, United States

16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized. With more than 30% of the FDA-approved parenterals lyophilized and soon more than half injectable drugs to require lyophilization there is ample room for standardization and expansion of the lyophilization process in pharmaceuticals.

However, lyophilization is one of the most time consuming and expensive unit operations. There are many issues within lyopilization which need addressing, and improved drying technologies are needed for current and future products.

Join us this November 2018, as we look toward the future of lyophilization. Network with industry experts, discuss regulatory challenges and unmet needs within lyophilization, gain insights into innovative technologies and strategies to overcome these challenges, discover new methods of scale-up and technology transfer, and explore alternative processes beyond conventional lyophilisation.

Benefits of Attending

Developing on last years' success, Lyophilization USA 2018 will bring together industry experts to discuss and analyze the latest advancements and challenges within lyophilization. Some notable areas of interest have been new technologies and developments within lyophilization, challenges and unmet needs in lyophilization, regulatory challenges and validation of lyophilized products, scale-up and transfer and alternatives beyond conventional lyophilization methods

At the 4th Annual Lyophilization USA 2018 Conference you will gain insight into:
  • Continuous freeze-drying technologies
  • Developments in bulk lyophilization technology
  • How to overcome challenges in lyophilization of high concentrated solutions and high density biologic materials
  • Process optimization of lyophilization from a regulatory perspective
  • Strategies to validate the lyophilization process
  • Methods beyond lyophilization: Spray drying, foam drying and microwave drying
  • Use of artificial intelligence in lyophilisation

Plus Two Half-Day Pre-Conference Workshops | Wednesday 14th November 2018

Workshop A: Current and Future Freeze-Drying Technologies and Methods
Workshop Leaders:  Alexander Tambovzev, Project Engineering and Development Leader, Optima Pharma
Dena Flamm, Business Development Manager, Optima Pharma
Tom Robinson, Managing Director, Aerosol Therapeutics
08.30am - 12.30pm

Workshop B: NIPTE Workshop on Freeze-Drying/Lyophilization Fundamentals
Workshop Leader: Robin Bogner, Professor in Pharmaceutics, University of Connecticut
13.30pm - 17.30pm


  • Alex Langford, Senior Assoicate Scientist, Pfizer Inc
  • Alina Alexeenko, Associate Professor, Purdue University
  • Colin Campbell, Director, Process Development, Elusys Therapeutics
  • Dena Flamm, Business Development Manager, Optima Machinery Corporation
  • Fabrice Schlegel, Senior Engineer, Amgen
  • Hiten Gutka, Principal Scientist Formulation Development Biosimilar Development, Oncobiologics
  • Mohamed AbouGhaly, Post-Doctoral Research Associate, Purdue University
  • Morrisa Jones, Senior Scientist, Merck
  • Mrinal Shah, Sr. Manager, Global Pharmaceutical Technology, Allergan
  • Pouya Tavousi, Postdoctoral Fellow, University Of Connecticut
  • Robin Bogner, Professor of Pharmaceutics , University Of Connecticut
  • Rui Fang, Senior Scientist, Merck Research Laboratories
  • Sampreeti Jena, Postdoctoral Associate, University of Minnesota
  • Sushma Kommareddy, Associate Director, Takeda
  • Timothy McCoy, Associate Director, Pharmaceutical Development Biologics , Sanofi
  • Tom Robinson, Managing Director, Aerosol Therapeutics
  • Yanming Zu, Director, R&D, Abon Pharmaceuticals LLC


Renaissance Woodbridge Hotel
515 US Highway 1 South
Iselin, New Jersey, USA
Event details
Organizer : SMi Life Sciences
Venue : Renaissance Woodbridge Hotel, Iselin, NJ, United States
Event type : Conference
Reference : ASDE-18954